I need to see in-depth competitive drug information

My ROI? A competitive drug profile in less than 24 hours — and from one comprehensive resource.

"Management asked me to put together a profile on a potential partner company for a meeting — the next day. I had to pull it together fast, but I couldn't cut any corners. With Thomson Reuters Pharma™, I didn't have to."

Seeing the big picture is critical when evaluating the competitive landscape. Before considering a meeting with a potential partner, it was essential for Robert to understand the company's profile, market position, recent deals, and current financials. What's more, he needed to gather all data available on their pipeline potential, strengths and weaknesses, novel mechanisms of action of the compound, patent protection, and more.

Using multiple sources, this type of research could take days — but not with Thomson Reuters Pharma. Robert was easily able to:

  • View drug profiles — drug discovery and development, patent protection, chemical structure, target/MOA, SWOT analyses, indications in development, and details on discovery stage, pre-clinical and clinical trials information
  • View company profiles — description of areas of focus, financial state, drug pipeline, and listing of significant partnerships and drug licensing deals
  • View drug licensing deals, searchable by therapy area, stage of deal, and announced deal structures

All the information is indexed, cross-referenced, and a click away. And, it's all prepared by industry experts at Thomson Reuters.
Sophisticated search and visualization tools in Thomson Reuters Pharma enabled Robert to manipulate the data and export the critical intelligence he needed. No other pharmaceutical database puts so much knowledge at your fingertips.

Pipeline. Deals. Companies. All from a single comprehensive source trusted by 100 PERCENT of the top 20 pharmaceutical companies. Now that's a smart investment.

Get More Information — WATCH OUR DEMO and get free report

Now you've seen what Thomson Reuters Pharma did for Robert, why not see some more of what Thomson Reuters Pharma can do for you and your business.

Simply fill out the form below in order to see a recorded video demonstration of Thomson Reuters Pharma. We'll also give you a new complimentary therapy area report, focusing on key market players and deals highlights in the Obesity area.

View a demo and download complimentary report